OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The application of ubiquitin ligases in the PROTAC drug design
Yilin Chen, Jianping Jin
Acta Biochimica et Biophysica Sinica (2020) Vol. 52, Iss. 7, pp. 776-790
Closed Access | Times Cited: 19
Yilin Chen, Jianping Jin
Acta Biochimica et Biophysica Sinica (2020) Vol. 52, Iss. 7, pp. 776-790
Closed Access | Times Cited: 19
Showing 19 citing articles:
An overview of PROTACs: a promising drug discovery paradigm
Liu Zi, Mingxing Hu, Yang Yu, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 153
Liu Zi, Mingxing Hu, Yang Yu, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 153
PROTAC technology: From drug development to probe technology for target deconvolution
Si Yan, Guangshuai Zhang, Wei Luo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116725-116725
Closed Access | Times Cited: 19
Si Yan, Guangshuai Zhang, Wei Luo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116725-116725
Closed Access | Times Cited: 19
Applications of protein ubiquitylation and deubiquitylation in drug discovery
Yilin Chen, Haoan Xue, Jianping Jin
Journal of Biological Chemistry (2024) Vol. 300, Iss. 5, pp. 107264-107264
Open Access | Times Cited: 17
Yilin Chen, Haoan Xue, Jianping Jin
Journal of Biological Chemistry (2024) Vol. 300, Iss. 5, pp. 107264-107264
Open Access | Times Cited: 17
Current advances of small molecule E3 ligands for proteolysis-targeting chimeras design
Dazhao Mi, Yuzhan Li, Haijun Gu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115444-115444
Closed Access | Times Cited: 27
Dazhao Mi, Yuzhan Li, Haijun Gu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115444-115444
Closed Access | Times Cited: 27
CRISPR-Cas9 high-throughput screening to study drug resistance in Leishmania infantum
Marine Queffeulou, Philippe Leprohon, Christopher Fernandez‐Prada, et al.
mBio (2024) Vol. 15, Iss. 7
Open Access | Times Cited: 7
Marine Queffeulou, Philippe Leprohon, Christopher Fernandez‐Prada, et al.
mBio (2024) Vol. 15, Iss. 7
Open Access | Times Cited: 7
PROTACs, molecular glues and bifunctionals from bench to bedside: Unlocking the clinical potential of catalytic drugs
Marı́a Maneiro, Elena De Vita, Daniel Conole, et al.
Progress in medicinal chemistry (2021), pp. 67-190
Closed Access | Times Cited: 36
Marı́a Maneiro, Elena De Vita, Daniel Conole, et al.
Progress in medicinal chemistry (2021), pp. 67-190
Closed Access | Times Cited: 36
A Comprehensive Overview of Protacs Targeting Hsp90 and Their Client Proteins for Cancer Therapy
Gulshan Kumar, Gouri Tyagi, Vikramdeep Monga
(2025)
Closed Access
Gulshan Kumar, Gouri Tyagi, Vikramdeep Monga
(2025)
Closed Access
Small-Molecule PROTACs for Cancer Immunotherapy
Zefan Liu, Yajun Zhang, Yucheng Xiang, et al.
Molecules (2022) Vol. 27, Iss. 17, pp. 5439-5439
Open Access | Times Cited: 14
Zefan Liu, Yajun Zhang, Yucheng Xiang, et al.
Molecules (2022) Vol. 27, Iss. 17, pp. 5439-5439
Open Access | Times Cited: 14
Tommaso Palomba, Massimo Baroni, Simon Cross, et al.
Chemical Biology & Drug Design (2022) Vol. 101, Iss. 1, pp. 69-86
Closed Access | Times Cited: 13
PROTACs in gastrointestinal cancers
Yu Chen, Qingfan Yang, Jinrun Xu, et al.
Molecular Therapy — Oncolytics (2022) Vol. 27, pp. 204-223
Open Access | Times Cited: 13
Yu Chen, Qingfan Yang, Jinrun Xu, et al.
Molecular Therapy — Oncolytics (2022) Vol. 27, pp. 204-223
Open Access | Times Cited: 13
PROTACs: The Future of Leukemia Therapeutics
Zubair Anwar, Muhammad Shahzad Ali, Antonio Galvano, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 8
Zubair Anwar, Muhammad Shahzad Ali, Antonio Galvano, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 8
Therapeutic approaches targeting oncogenic proteins in myeloid leukemia: challenges and perspectives
Xing Yan, Yuan Yuan Kang, Ze Yan Zhang, et al.
Expert Opinion on Therapeutic Targets (2024)
Closed Access | Times Cited: 1
Xing Yan, Yuan Yuan Kang, Ze Yan Zhang, et al.
Expert Opinion on Therapeutic Targets (2024)
Closed Access | Times Cited: 1
Targeting Oncoproteins for Degradation by Small Molecule-Based Proteolysis-Targeting Chimeras (PROTACs) in Sex Hormone-Dependent Cancers
Li Liu, Lihong Shi, Zhaodi Wang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 6
Li Liu, Lihong Shi, Zhaodi Wang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 6
N-Heterocycle based Degraders (PROTACs) Manifesting Anticancer Efficacy: Recent Advances
Suddhasatwa Banerjee, Sachin Sharma, Amandeep Thakur, et al.
Current Drug Targets (2023) Vol. 24, Iss. 15, pp. 1184-1208
Closed Access | Times Cited: 3
Suddhasatwa Banerjee, Sachin Sharma, Amandeep Thakur, et al.
Current Drug Targets (2023) Vol. 24, Iss. 15, pp. 1184-1208
Closed Access | Times Cited: 3
Intersections of Ubiquitin-Proteosome System and Autophagy in Promoting Growth of Glioblastoma Multiforme: Challenges and Opportunities
Rhett Visintin, Swapan K. Ray
Cells (2022) Vol. 11, Iss. 24, pp. 4063-4063
Open Access | Times Cited: 4
Rhett Visintin, Swapan K. Ray
Cells (2022) Vol. 11, Iss. 24, pp. 4063-4063
Open Access | Times Cited: 4
PROTACs: A Hope for Breast Cancer Patients?
Rajwinder Kaur, Gaurav Chaudhary, Amritpal Kaur, et al.
Anti-Cancer Agents in Medicinal Chemistry (2021) Vol. 22, Iss. 3, pp. 406-417
Closed Access | Times Cited: 4
Rajwinder Kaur, Gaurav Chaudhary, Amritpal Kaur, et al.
Anti-Cancer Agents in Medicinal Chemistry (2021) Vol. 22, Iss. 3, pp. 406-417
Closed Access | Times Cited: 4
A special issue on the 10-year anniversary of Life Sciences Institute, Zhejiang University
Xin Hua Feng
Acta Biochimica et Biophysica Sinica (2020) Vol. 52, Iss. 7, pp. 701-701
Open Access
Xin Hua Feng
Acta Biochimica et Biophysica Sinica (2020) Vol. 52, Iss. 7, pp. 701-701
Open Access
Applications of Targeted Protein Degradation in Drug Discovery
Ji-Qiang Jin
Annals of Chemical Science Research (2021) Vol. 2, Iss. 4
Open Access
Ji-Qiang Jin
Annals of Chemical Science Research (2021) Vol. 2, Iss. 4
Open Access
